Promoting HPV Vaccination in Rural Communities
PREVENT: Practice-based Approaches to Promote HPV Vaccination in the Safety Net - Randomized Controlled Trial (RCT)
This study is testing different ways to encourage parents in rural areas to get their children vaccinated against HPV.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 519 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University of Utah Academic / other |
| Locations | 1 site (Seattle, Washington) |
| Trial ID | NCT06738355 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to develop and test strategies to enhance HPV vaccination rates among parents and caregivers of children aged 9-17 in rural areas of the Mountain West. The study will implement a randomized controlled trial at four community clinics, utilizing tailored messaging based on input from patients and providers. Participants will receive different types of reminders to encourage timely vaccination, with the effectiveness of these interventions being assessed through completion rates of the HPV vaccine series. The study will also include qualitative interviews to gather insights from parents, caregivers, and healthcare providers.
Who should consider this trial
Good fit: Ideal candidates for this study are parents or caregivers of children and adolescents aged 9-17 who have visited a participating clinic in the last year and speak either English or Spanish.
Not a fit: Patients who have already completed the HPV vaccination series or have clinical conditions that exclude them from CDC recommendations may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the incidence of HPV-related cancers in rural populations by increasing vaccination rates.
How similar studies have performed: Other studies have shown success in increasing vaccination rates through tailored reminder interventions, suggesting that this approach may be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Parents/Caregivers (P/C) of children/adolescents (C/A) ages 9-17 years of age (i.e., age-eligible for HPV vaccination); 2. P/C with active clinic patients (i.e., have been seen in the clinic in the last 12 months); and 3. P/C who speak either English or Spanish. Exclusion Criteria: 1. P/C of C/A with previous excluding HPV vaccination history (e.g., completed vaccination, or not due); 2. P/C of C/A with clinical conditions that influence the CDC HPV vaccination recommendations (e.g., pregnancy); 3. P/C of C/A with other factors that would influence CDC HPV recommendations; and 4. P/C that does not speak Spanish or English.
Where this trial is running
Seattle, Washington
- Sea Mar Community Health Centers — Seattle, Washington, United States (Recruiting)
Study contacts
- Principal investigator: Deanna Kepka, PhD, MPH — Study Principal Investigator
- Study coordinator: Kaila Christini, MsPH, MS
- Email: Kaila.Christini@hci.utah.edu
- Phone: 801-587-4565
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.